| Sowjanya Bhagavatula, MD | |
|
14139 Potomac Mills Rd, Woodbridge, VA 22192-4644 | |
| (703) 490-8400 | |
| Not Available |
| Full Name | Sowjanya Bhagavatula |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 22 Years |
| Location | 14139 Potomac Mills Rd, Woodbridge, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003020975 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | NA (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
Relapses after treatment for Leishmania infection may be due to a greater infectivity of the parasite rather than drug resistance, as has been previously thought, according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.
For many people with chronic health conditions, it can be tough to navigate through the complex healthcare system. Mary, a 65 year old woman with several conditions including diabetes, arthritis, high blood pressure and high cholesterol, visits specialists for each of these conditions - an endocrinologist, rheumatologist and cardiologist - in addition to her primary care physician.
A new study has uncovered a link between being overweight or obese in adolescence and an increased risk of developing colon cancer in adulthood. Obesity was also associated with an elevated risk of developing rectal cancer.
The new tool, the first Huntington's disease-specific quality of life instrument of its kind, aims to fully capture the impact of this complex disease on the everyday life of sufferers. By using this new tool to more accurately measure the impact of Huntington's and also any effect of therapeutic interventions, scientists will be in a better position to evaluate the usefulness of interventions on patients' everyday quality of life to see if there is actually a practical benefit. It is hoped that in this way, this tool will lead to more effective treatments.
Researchers at Fox Chase Cancer Center uncovered a genetic pattern that may help predict how gastrointestinal stromal tumor (GIST) patients respond to the targeted therapy imatinib mesylate (Gleevec). Moreover, their findings point to genes that could be suppressed in order to make these tumors respond more readily to imatinib.
› Verified 4 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861552721 PECOS PAC ID: 3779495858 Enrollment ID: O20031105000744 |
News Archive
Relapses after treatment for Leishmania infection may be due to a greater infectivity of the parasite rather than drug resistance, as has been previously thought, according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.
For many people with chronic health conditions, it can be tough to navigate through the complex healthcare system. Mary, a 65 year old woman with several conditions including diabetes, arthritis, high blood pressure and high cholesterol, visits specialists for each of these conditions - an endocrinologist, rheumatologist and cardiologist - in addition to her primary care physician.
A new study has uncovered a link between being overweight or obese in adolescence and an increased risk of developing colon cancer in adulthood. Obesity was also associated with an elevated risk of developing rectal cancer.
The new tool, the first Huntington's disease-specific quality of life instrument of its kind, aims to fully capture the impact of this complex disease on the everyday life of sufferers. By using this new tool to more accurately measure the impact of Huntington's and also any effect of therapeutic interventions, scientists will be in a better position to evaluate the usefulness of interventions on patients' everyday quality of life to see if there is actually a practical benefit. It is hoped that in this way, this tool will lead to more effective treatments.
Researchers at Fox Chase Cancer Center uncovered a genetic pattern that may help predict how gastrointestinal stromal tumor (GIST) patients respond to the targeted therapy imatinib mesylate (Gleevec). Moreover, their findings point to genes that could be suppressed in order to make these tumors respond more readily to imatinib.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sowjanya Bhagavatula, MD 14139 Potomac Mills Rd, Woodbridge, VA 22192-4644 Ph: (703) 490-8400 | Sowjanya Bhagavatula, MD 14139 Potomac Mills Rd, Woodbridge, VA 22192-4644 Ph: (703) 490-8400 |
News Archive
Relapses after treatment for Leishmania infection may be due to a greater infectivity of the parasite rather than drug resistance, as has been previously thought, according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.
For many people with chronic health conditions, it can be tough to navigate through the complex healthcare system. Mary, a 65 year old woman with several conditions including diabetes, arthritis, high blood pressure and high cholesterol, visits specialists for each of these conditions - an endocrinologist, rheumatologist and cardiologist - in addition to her primary care physician.
A new study has uncovered a link between being overweight or obese in adolescence and an increased risk of developing colon cancer in adulthood. Obesity was also associated with an elevated risk of developing rectal cancer.
The new tool, the first Huntington's disease-specific quality of life instrument of its kind, aims to fully capture the impact of this complex disease on the everyday life of sufferers. By using this new tool to more accurately measure the impact of Huntington's and also any effect of therapeutic interventions, scientists will be in a better position to evaluate the usefulness of interventions on patients' everyday quality of life to see if there is actually a practical benefit. It is hoped that in this way, this tool will lead to more effective treatments.
Researchers at Fox Chase Cancer Center uncovered a genetic pattern that may help predict how gastrointestinal stromal tumor (GIST) patients respond to the targeted therapy imatinib mesylate (Gleevec). Moreover, their findings point to genes that could be suppressed in order to make these tumors respond more readily to imatinib.
› Verified 4 days ago
Dr. Uzma Amer Mian, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4899 Prince William Pkwy, Woodbridge, VA 22192 Phone: 833-510-4357 | |
Dr. Jack C Huang, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14010 Smoketown Rd, Suite 117, Woodbridge, VA 22192 Phone: 703-580-0181 Fax: 703-897-8763 | |
Maria Joy Flick, FNP-C Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 12872 Harbor Dr, Woodbridge, VA 22192 Phone: 540-207-9303 | |
Dr. Nizar Mohamed Hussain, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Opitz Blvd, Woodbridge, VA 22191 Phone: 703-494-4116 Fax: 703-497-0051 | |
Fiona Mienko, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2280 Opitz Blvd, Woodbridge, VA 22191 Phone: 703-590-8300 Fax: 703-590-8301 | |
Elena Short, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14139 Potomac Mills Rd, Woodbridge, VA 22192 Phone: 703-359-7878 |